Equities
  • Price (EUR)7.90
  • Today's Change-0.150 / -1.86%
  • Shares traded200.00
  • 1 Year change+18.80%
  • Beta--
Data delayed at least 15 minutes, as of Jan 21 2022 07:16 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

ALS Limited is an Australian-based company, which is engaged in providing laboratory testing, inspection, certification and verification solutions. The Company operates through three segments: Life Sciences, Commodities, and Industrial. Its Life Sciences segment provides analytical testing, sampling services and remote monitoring for the environmental, food, pharmaceutical, and consumer product markets. Its Commodities segment provides testing services for the global mining industry in four business streams, which includes geochemistry, metallurgy, inspection, and coal quality. Its Industrial segment is a provider of diagnostic testing and engineering solutions for the energy, resources, transportation, and infrastructure sectors. The Company operates from approximately 350 sites in over 65 countries across Africa, Asia, Australia, Europe and the Americas.

  • Revenue in AUD (TTM)1.95bn
  • Net income in AUD176.40m
  • Incorporated1910
  • Employees15.91k
  • Location
    ALS LtdLevel 2, 299 Coronation Drive, MiltonBRISBANE 4064AustraliaAUS
  • Phone+61 73367-7900
  • Fax+61 73367-8156
  • Websitehttps://www.alsglobal.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ALQ:ASX since
announced
Transaction
value
MinAnalytical Laboratory Services Australia Pty LtdAnnounced17 Dec 202117 Dec 2021Announced-5.51%31.32m
Investiga Pesquisas Clinicas LtdaDeal completed08 Mar 202108 Mar 2021Deal completed30.14%--
Data delayed at least 20 minutes, as of Jan 21 2022 05:10 GMT.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.